期刊文献+

乳腺癌中Tenascin C、α-SMA和PDGFRα的表达及意义 被引量:5

Expression of Tenascin C, α-SMA, PDGFRα in breast cancer and their significance
下载PDF
导出
摘要 目的探讨乳腺癌组织间质成纤维细胞活化相关分子标记Tenascin C(TN-C)、α-SMA和PDGFRα的表达,明确其与乳腺浸润性导管癌临床病理特征的关系。方法采用免疫组化SP法检测81例乳腺浸润性导管癌间质及癌细胞中TN-C、α-SMA和PDGFRα蛋白表达水平,分析这三者与乳腺癌临床病理特征的关系。结果在乳腺腺病、乳腺导管内癌和浸润性导管癌三种不同病变中,TN-C在间质成纤维细胞中的阳性率分别为0、0、51.9%(P<0.001);α-SMA的阳性率分别为0、20.0%、70.4%(P<0.001);PDGFRα的阳性率分别为10.0%、0、37.0%(P<0.01)。三者在间质表达均与乳腺癌分子亚型相关(P<0.05),且均在HER-2阳性乳腺癌间质中的表达水平最高。TN-C、α-SMA和PDGFRα在乳腺癌细胞中的表达水平明显低于导管内癌或乳腺腺病,其中TN-C在癌细胞中表达水平与患者年龄有关(P<0.05),乳腺癌细胞α-SMA表达水平与淋巴结转移显著相关(P<0.05),但PDGFRα在癌细胞中表达水平与患者年龄、肿瘤组织学分级、肿瘤分期、淋巴结转移、分子分型均无明显相关性(P>0.05)。结论与乳腺腺病和乳腺导管内癌相比,乳腺浸润性导管癌间质成纤维细胞中TN-C、α-SMA和PDGFRα的表达水平明显增高,并与乳腺癌分子分型存在明显相关性。提示间质成纤维细胞活化是促进乳腺癌恶性演进的重要因素,成纤维细胞活化相关分子有望成为乳腺癌临床预后的分子标记。 Purpose To investigate the expression of molecular markers related to fibroblast activation in the stroma of breast cancer, and to determine the correlation with the clinicopathological features of breast invasive ductal carcinoma. Method The expression of Tenascin-C (TN-C),α-SMA and PDGFRα in 81 cases of breast cancer was detected by immunohistochemistry, and the relationship was analysed between these molecules and the clinicopathological features of breast cancer. Results Among the breast adenosis, ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC), the expression of TN-C in the stromal fibroblasts was detected as 0, 0, and 51.9%, respectively ( P <0.001). The positive rates of α-SMA in stroma was 0, 20.0%, 70.4%( P <0.001) and those of PDGFRα in three types of breast lesions was 10.0%, 0, 37.0%( P <0.01), respectively. The expression of these proteins in the stroma was closely correlated with different molecular subtype of IDC ( P <0.05), and higher positive level of these proteins was detected in the stroma of HER-2 + breast carcinoma compared with luminal and triple negative breast cancer. In contrast, the expression of TN-C,α-SMA and PDGFRα in the epithelial compartments of IDC was significantly lower than those in DCIS or breast adenosis. In addition, the expression of TN-C in the epithelium of breast cancer was related to the patient’s age ( P <0.05), and high expression of α-SMA in epithelial compartment was correlated with lymph node involvement of breast cancer ( P < 0.05). However, the expression of PDGFRα in the breast cancer epithelial cells showed no significant correlation with patient’s age, histological grade, tumor stage, lymph node metastasis and molecular subtypes ( P >0.05). Conclusion In summary, compared with breast adenosis and DCIS, high expression of TN-C,α-SMA and PDGFRα is detected in the stroma of IDC and closely associated with the development of HER-2 + breast cancer, indicating that activation of stromal fibroblasts may provide the permissive niche that cooperates with activation of oncogene in tumor cells to promote progression of breast carcinoma and to result in worse clinical outcome.
作者 张哲珺 陆元志 钟雪云 ZHANG Zhe-jun;LU Yuan-zhi;ZHONG Xue-yun(Department of Pathology, the First Affiliated Hospital of Ji'nan University, Guangzhou 510630, China)
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2019年第9期1013-1017,共5页 Chinese Journal of Clinical and Experimental Pathology
基金 国家自然科学基金面上项目(81372298、81572606) 广东省“扬帆计划”引进紧缺拔尖人才项目(201433007)
关键词 乳腺肿瘤 癌相关成纤维细胞 肿瘤微环境 转移 breast neoplasm cancer-associated fibroblasts tumor microenvironment metastasis
  • 相关文献

参考文献3

二级参考文献34

  • 1张瑰红,施达仁,梁晓曼,侯景辉,康苏娅,朱卫东,李晓兵,邵云,陈丽荣,周燕.显色原位杂交和免疫组织化学检测乳腺癌HER2/neu基因状况和蛋白表达的对照性研究[J].中华病理学杂志,2006,35(10):580-583. 被引量:29
  • 2<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量:164
  • 3张雅青,顾克东.基质金属蛋白酶与肿瘤关系研究进展[J].西北民族大学学报(自然科学版),2006,27(3):79-84. 被引量:10
  • 4孙强.乳腺癌的早期诊断[J].实用医学杂志,2007,23(1):1-3. 被引量:77
  • 5马日海,汪建初,浦涧.乳腺癌肉瘤10例临床诊治分析[J].实用医学杂志,2007,23(10):1521-1521. 被引量:9
  • 6Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer [ J]. J Clin Oncol, 2007, 25 (33) :5287-5312.
  • 7Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Chnical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer[ Jl. J Clin Oncol, 2007, 25 ( 1 ) : 118- 145.
  • 8Wolff AC, Hammond ME, Hicks DG, et al. Recommendations for human epidermal growth faetor reeeptor 2 testing in breast eaneer: American Society of Clinical Oneology/College of American Pathologists clinical practice guideline update[J]. J Clin Oneol, 2013, 31 (31) :3997-4013.
  • 9Hanna WM, Kwok K. Chromogenic in-situ hybridization:a viable ahernative to fluorescence in-situ hybridization in the HER2 testing algorithm[J]. Mod Pathol, 2006, 19(4) :481-487.
  • 10Park K, Han S, Kim JY, et al. Silver-enhanced in situ hybridization as an alternative to fluorescence in situ hybridization for assaying HER2 amplification in clinical breast cancer [ J ]. J Breast Cancer, 2011, 14(4) :276-282.

共引文献333

同被引文献48

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部